Company Lexington BioSciences Inc Canadian Securities Exchange
Equities
CA5290201097
Medical Equipment, Supplies & Distribution
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Donald McInnes
CEO | Chief Executive Officer | 60 | 16/20/16 |
Bryan Disher
DFI | Director of Finance/CFO | 66 | 21/16/21 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Bryan Disher
DFI | Director of Finance/CFO | 66 | 21/16/21 |
Tamara Manuel
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 23,669,560 | 0 | 0 | 13.79 % |
Stock B | 1 | 3,786,840 | 3,785,340 ( 99.96 %) | 0 |
Company contact information
Lexington Biosciences, Inc.
1055 West Hastings Street Suite 1900
V6E 2E9, Vancouver
+
Sector
1st Jan change | Capi. | |
---|---|---|
-7.16% | 178B | |
-1.23% | 107B | |
-4.86% | 67.04B | |
-4.28% | 47.23B | |
+10.32% | 44.62B | |
+8.14% | 42.5B | |
+15.53% | 25.22B | |
-5.88% | 24.14B | |
-5.38% | 23.69B |